REJO MULTI Unveiled at InterTabac 2025, Featuring Dual-Heating and Cross-Brand Compatibility
19.9.2025 11:00:00 EEST | Business Wire | Press release
REJO, a global heat-not-burn (HNB) pioneer, officially unveiled REJO MULTI device at InterTabac 2025 as one of the exhibition’s most anticipated products. The device introduces a dual-heating system that pairs AirFlow and Round Heating technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919713971/en/
REJO MULTI Product Launch Event
“REJO MULTI represents a major step forward in HNB technology,” said Loic Li, the Global Sales Director of REJO. “Its open compatibility allows users to explore multiple brands and flavors with a single device, while our dual-heating system ensures even heating, enhanced aroma delivery, and consistent nicotine satisfaction.”
“Our goal with REJO MULTI is to empower users with choice and flexibility, while providing retailers and partners with an innovative, market-ready product that elevates the smoking alternative experience,” said Tibor Braun, the Western Europe Manager of REJO. “This launch underscores REJO’s commitment to open innovation and collaborative growth in the European market and beyond.”
The device incorporates advanced thermal control algorithms, an optimized power management system, and a lightweight, portable design at 82 grams. Users can benefit from up to 40 stick sessions per charge, with preheating achieved in under 20 seconds, offering convenience for daily use. The REJO MULTI is available in Twilight Purple, Aurora Green, and Luminous Grey, with a global launch scheduled for November 2025.
User benefits include:
- Flexibility: One device supports multiple brands, giving consumers freedom to select preferred flavors and smoking alternative experiences.
- Efficiency: Dual-heating technology maximized aroma and cloud production while reducing overall tobacco consumption by enabling two sessions per stick in round-heating mode.
- Portability: Lightweight and ergonomic design ensures ease of use in any setting.
European Expansion and Regulatory Readiness
2025 has been a milestone year for REJO’s European expansion. The company introduced its innovative portfolio - including TOZE herbal sticks, the REJO HS40 heating device, and advanced FARSTAR NSCs technology - to key markets such as Switzerland and Germany. TOZE sticks, inspired by East Asia’s tea-based tradition, pair seamlessly with the REJO HS40 to deliver consistent, high-quality flavor experience.
REJO has secured essential European regulatory approvals, reinforcing readiness to compete in the HNB market.
Community Engagement and REJO Club
Beyond product innovation, REJO continues to cultivate its REJO club, integrating online and offline community experiences. Following the success of the TENSION event in Switzerland, REJO aims to deepen global engagement through ongoing events, local support, and collaborative partnerships.
At InterTabac, REJO’s R&D Director participated in a forward-looking panel, highlighting the company’s commitment to innovation and industry leadership under its guiding principle: "Stay Courageous. Be Undefined."
A New Invitation: Take a Break. Take REJO.
REJO MULTI is more than a device - it represents a commitment to user choice, convenience, and advanced HNB technology. Through open compatibility, collaborative partnerships, and bold innovation, REJO is redefining how consumers engage with HNB products across global markets.
About REJO
REJO is a global provider of heat-not-burn (HNB) solutions, focused on delivering innovative, reliable, and open product options. Through collaboration with partners and its global community, REJO empowers users to break free from restrictive brand or flavor limitations and explore a broader range of experiences.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250919713971/en/
Contacts
Media Contact:
Email: Newsroom@rejonow.com
Website: www.rejonow.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.rejonow.com
&esheet=54326768&newsitemid=20250919713971&lan=en-US&anchor=www.rejonow.com&inde
x=1&md5=f0ddf4315559534d950552fa9c271946
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences23.9.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin longevity and evidence-based care. “At Galderma, we recognize that advancing dermatology means not only addressing the needs of patients living with common chronic skin conditions, such as atopic dermatitis and acne, but also anticipating the trends that will shape the future of skin health. Our presence at EADV demonstrates our unique ability to achieve this, with new data spanning both established areas of unmet need and emerging fields such as skin longevity, helping drive innovation and meaningful outcomes for patients today and i
Oticon Medical Launches SmartCharger for the Ponto 5 Family23.9.2026 08:00:00 EEST | Press release
Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922863462/en/ Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. Powering the Ponto 5 family The launch of SmartCharger underlines Oticon Medical’s continued commitment to the Ponto family, which includes Ponto 5 SuperPower, the world’s most powerful abutment-level sound processor,1 and Ponto 5 Mini, the world’s smallest percutaneous sound processor.1 By bringing rechargeable convenience to the Ponto sound processors, Oticon Me
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom